Search results for: 'Pipeline Assessment for Cardiovascular Diseases'

Wound assessment and monitoring systems are devices or digital aids that enable the measurement, imaging, and documentation of wounds by providing 3D assessment of a wound with EMR software integration. With inadequate wound care resulting in various debilitating healthcare-associated infections and adding to the cost burden of patients, modern dig...

This research service covers the U.S. injectable drug pipeline in 2009. Included are technology trends, Phase III pipeline analysis, selected Phase II and I pipeline analysis. The market is segmented by injectable drug delivery route: subcutaneous injectables, intravenous injectables, intramuscular injectables, and others. Major market challenges,...

This research service covers the pharmaceutical industry development pipeline for diabetes mellitus in the United States, with 2005 as the base year. Included are both the products projected to enter the market by the end of the forecast coverage period in 2012, as well as products entering the market in 2005 that correspond to the in-depth discuss...

This research study covers the airport security market in Middle East. The research study discusses the trends in new technology growing in this region, the industry challenges and market drivers and restraints for this region.

The increased demand for fibrinogen and the development of innovative delivery systems such as sprays and patches are fuelling the growth of the fibrinogen market. This research service provides a detailed assessment of the global fibrinogen market, covering the current market scenario and growth prospects for the period 2015–2020. Both marketed an...

05 Aug 2024  |  Global  |  Technology Research

CGT Research Outlook and Technology Growth Opportunities

CGT Landscape Assessment

Infographics

×

The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and clinical success rates has led to the growing demand for the development of new technology platforms, manufacturing capabilities, a...

TechVision's latest research service from the medical device technology cluster highlights the game changing innovations in cardiovascular care. Although cardiovascular devices have been in use for decades, over the last few years, there have been some major developments in cardiovascular care. The technology innoavtions are powered by rapid advanc...

This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacif...

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...